Is Ipamorelin Banned in Sports? WADA S2.2.4, NCAA and Drug Tests

S2.2.4 is the densest section of the List for growth-hormone-axis peptides. It covers three groups, all prohibited at all times:

• GHRH and its analogues, with examples CJC-1293, CJC-1295, sermorelin and tesamorelin.
• Growth hormone secretagogues and their mimetics, with examples anamorelin, capromorelin, ibutamoren (MK-677), ipamorelin, lenomorelin (ghrelin), macimorelin and tabimorelin.
• GH-releasing peptides (GHRPs), including alexamorelin, examorelin (hexarelin) and GHRP-1 through GHRP-6.

Ipamorelin is named individually. There is no argument that it is merely implied by a catch-all, and no reading under which it is permitted out of competition.

Why it sits in S2 rather than S0

S0 is the catch-all for substances not addressed by any other section. Ipamorelin is addressed directly by S2.2.4, so S0 does not come into it. The practical difference is that S0 substances are Specified, while S2 substances are non-Specified, which matters at the sanctioning stage. It does not make either one more permitted.

Prices are all-in monthly figures covering the medication, physician review, refill management and shipping. There is no separate membership fee. Switching from one ipamorelin product to another changes nothing for a tested athlete.

Yes. In 2015 Drug Testing and Analysis published the determination of growth hormone releasing peptide metabolites in human urine, covering GHRP-1, GHRP-2, GHRP-6, hexarelin and ipamorelin, which is a study of exactly this class. A 2016 paper in the Journal of Separation Science described a direct-urine-injection screen covering peptides under 2 kDa, and a 2026 paper in The Analyst described a harmonised workflow for peptidic doping agents in blood matrices.

Detection windows for small peptides are generally short, often hours to a few days. That is not a reason to use one. Under Code Article 6.6 a negative sample can be stored and reanalysed later, and Article 17 allows a charge within ten years of the asserted violation.

A separate point: IGF-1 on your bloodwork

Treatment on the growth-hormone axis can move IGF-1, a marker a clinician may look at. That is not a drug test result; it is a normal consequence of treatment, and it is a reason your medical record should be accurate. The difference between secretagogues and growth hormone itself is explained in peptides vs HGH.

Anti-doping rules are about what is permitted in sport, not about legality. Article 2.1.1 of the World Anti-Doping Code makes it the athlete's personal duty to ensure no prohibited substance enters their body, and intent, fault or negligence do not need to be shown.

Therapeutic use exemptions

A TUE requires a diagnosed medical condition supported by clinical evidence, no enhancement beyond a return to normal health, no reasonable permitted alternative, and a need not caused by earlier prohibited use. Growth hormone secretagogues are prohibited because of effects that overlap with performance, and permitted alternatives usually exist for the conditions people cite, so TUEs in this class are not a routine grant. USADA requires athletes in its testing pools to hold a TUE in advance; others are directed to the TUE Pre-Check Form, with a stated response time of three to five business days.

The NCAA bans "peptide hormones, growth factors, related substances and mimetics," with published examples including growth hormone and ibutamoren (MK-677). Ipamorelin is not one of the named examples, but the NCAA states that "any substance that is chemically/pharmacologically related to one of the above drug classes, even if it is not listed as an example, is also banned." Ipamorelin and ibutamoren are both growth hormone secretagogues. Talk to your athletics health care provider before starting anything.

Employment panels are fixed in regulation. The federal panel in 49 CFR 40.85 covers marijuana metabolites, cocaine metabolite, opiates, semi-synthetic opioids, 6-acetylmorphine, phencyclidine, amphetamines and MDMA. Ipamorelin, a five-amino-acid peptide, is not on it and has no structural relationship to any of its targets. See do peptides show up on a drug test.

Ipamorelin left Category 2 of the FDA's interim 503A list in September 2024, when the nominations were withdrawn. On 29 October 2024 the Pharmacy Compounding Advisory Committee voted 0 in favour, 12 against, with 1 abstention, on adding ipamorelin and ipamorelin acetate to the 503A Bulks List, for growth hormone deficiency and postoperative ileus, citing a lack of information supporting safety and efficacy for those uses. No final rule has been issued. Compounded medications are not FDA approved. None of this affects anti-doping status, which turns on the List, not on compounding.

Ipamorelin has no randomized human trials for the uses it is prescribed for in wellness practice, and the FDA's briefing noted no clinical data for the subcutaneous route. Being named on the List reflects the growth-hormone-axis mechanism, not a published finding that ipamorelin improves performance in athletes. The research is in what is ipamorelin and ipamorelin benefits, and the safety picture in ipamorelin side effects and is CJC-1295 / Ipamorelin safe.

The wider context is in peptides for athletes.

1. Complete a free online intake covering your history, medications and goals. If you compete in tested sport, say so on the intake and again in your first message to the physician.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a PCAB-accredited, FDA-registered US 503A pharmacy compounds it. Lot results are at /quality/lab-results.
4. It ships refrigerated with ice packs, sterile syringes and alcohol prep pads, with your directions printed on the vial.
5. Refills come every 28 days, one vial per fill.

The step-by-step page is how to get ipamorelin prescribed online. Pepti is cash-pay and does not bill insurance.